Evaluates the carcinogenic risk to humans posed by exposure to some Antineoplastic & Immunosupressive Agents.
JoHNSTON, B.J., NovALES, E.T.: Clinical effect of Coley's toxin – II. A seven year study. Cancer Chemother. Rep. 21, 43–68 (1962). KALIss, N.: Immunological enhancement in tumor homografts in mice. A review. Cancer Res.
... M. 820, 827 Coddington, A. 658, 665 Coe, R.O., Bull, F.E. 480 Coffey, D.S., Ichinose, R. R., Shimazaki, J. Williams-Ashman, H.G. 151, 153 Coffey, J.J., Kelley,S.A., Palm, P.E., Mead, J.A. R., Kensler, C.J. 800 802, 805 Coffey ...
Antineoplastic and Immunosuppressive Agents
Even in the present instance, it has proved necessary for practical reasons to publish the material in two parts, although the plan of the work constitutes, at least in the editors' view, a single integrated treatment of this research area.
This book describes recommended methods for disposing of carcinogenic wastes, including compounds widely used in hospital clinics and pharmacies. In such areas, it is less likely that fume cupboards and...
Antineoplastic and Immunosuppressive Agents
This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients.
Authoritative and integrative, Fluoropyrimidines in Cancer Therapy summarizes the latest preclinical and clinical experiences using fluoropyrimidines to treat colorectal cancer, delineates the underlying mechanisms and choices for therapy, ...
Gesellschaft zur Bekämpfung der Krebskrankheiten, Nordrhein- Westfalen e.V. and European Organization for Research on Treatment of Cancer. 5. Symposium in Düsseldorf, November 8, 9, 1973
Rodman JS , Deutsch DJ , Gutman SI . Methyldopa hepatitis : a report of six cases and review of the literature . Am J Med 60 : 941 , 1976 . 33. Seeff LB. Drug - induced chronic liver disease with emphasis on chronic active hepatitis .